Deep Capture Exposes Corruption In Provenge Approval Process
June 19th, 2009 | Posted by CTLMichael Milken, 60,000 Deaths, and the Story of Dendreon (Chapter 1 of 15)
18 June 2009 by Mark Mitchell
What follows is part 1 of a 15 part series. The remaining installments will appear on Deep Capture over the next several weeks, after which point the story will be published in its entirety. It is a story about the travails of just one small company, but it describes market machinations that have affected hundreds of other companies, and it contains a larger message for anyone concerned about the “deep capture” of our nation’s media and regulatory bodies.
This story, like too many others, begins with Jim Cramer, the CNBC personality, making “a mistake.”
On September 26, 2005, Cramer announced to his television audience the sad news (punctuated by funny sound effects – a clown horn, a crashing airplane) that Provenge, an experimental treatment for prostate cancer, had flopped. Thousands of end-stage patients had been pinning their hopes on Provenge, but according to Cramer the treatment had just been rejected by the Food & Drug Administration. It would never go to market.
Read It Here >>http://www.deepcapture.com/michael-milken-60000-deaths-and-the-story-of-dendreon/
http://www.deepcapture.com/michael-milken-60000-deaths-and-the-story-of-dendreon-chapter-1-of-15/
Popularity: 25%
Tags: , Care To Live, CareToLive, CNBC, Deep Capture, Dendreon, Jim Cramer, judd bagley, Kerry Donahue, mafia, Mark Mitchell. Patrick Byrne, Michael Milken, Prostate Cancer, provenge